Telerobotic partial nephrectomy and radical prostatectomy using a hybrid network: A single-center prospective experience [0.03%]
基于混合网络的机器人部分肾切除术和根治性前列腺切除术：单中心前瞻式研究经验报告
Pokhrel Gaurab,Shuanbao Yu,Haoke Zheng et al.
Pokhrel Gaurab et al.
Introduction: Advances in robotics and telecommunications have catalyzed resurgence of telerobotic surgery (TRS). This study aims to evaluate safety, feasibility, and clinical outcomes of TRS in partial nephrectomy (PN) a...
Changes in liver resections and associated outcomes over thirty years: a nationwide analysis using a machine learning approach [0.03%]
三十年来肝脏切除术变化及其相关结局的全国范围分析及机器学习方法应用
Koen H M Verdonschot,Pauline A J Vissers,Peter B van den Boezem et al.
Koen H M Verdonschot et al.
Background: In contrast to three decades ago, liver resection (LR) is now an increasingly common procedure. This study aims to evaluate changes in the number and indications of liver resections for malignancy over the pas...
Gerald Gui,Jennifer E Rusby,Marios Konstantinos Tasoulis
Gerald Gui
Implant based breast reconstruction (IBR) remains the most commonly performed reconstructive approach following mastectomy. Contemporary practice has evolved significantly through advances in implant technology, availability of biological a...
Association of multidisciplinary team management with clinical outcomes in hepatobiliary and pancreatic malignancies: A systematic review and meta-analysis [0.03%]
多学科团队管理与肝胆胰恶性肿瘤临床结局相关性系统评价和Meta分析
Shutong Shao,Kang Xue,Qiang Guo et al.
Shutong Shao et al.
Background: Multidisciplinary team (MDT) management is widely endorsed for complex hepatobiliary and pancreatic (HBP) malignancies. However, robust systematic evidence evaluating its survival benefits and heterogeneity ac...
Extended hepatectomy is associated with improved five- and ten-year survival rates in perihilar cholangiocarcinoma: a population-based analysis of the SEER database (2010-2022) [0.03%]
扩大肝切除术与周围型胆管癌五年和十年生存率改善相关：基于SEER数据库（2010-2022）的分析研究
Mahmoud Amer,Hanan El Youzouri,Ursula Pession et al.
Mahmoud Amer et al.
Background: The prognostic factors for long-term survival after resection of perihilar cholangiocarcinoma (pCCA) remain controversial, especially concerning the impact of an extended hepatectomy. This study aimed to ident...
Early postoperative intraperitoneal chemotherapy for pseudomyxoma peritoneii: A state of the art review [0.03%]
伪黏液瘤腹膜炎术后早期腹腔内化疗：现状分析
Yang Yu,Ashish Vaska,Nima Ahmadi et al.
Yang Yu et al.
Background: Cytoreductive surgery (CRS) followed by heated intraperitoneal chemotherapy (HIPEC) remains the mainstay of treatment for patients with pseudomyxoma peritonei (PMP). CRS and intraperitoneal chemotherapy (IPC) ...
Female sex is associated with improved outcomes after surgery for pancreatic neuroendocrine neoplasms [0.03%]
性别差异对胰腺神经内分泌肿瘤手术预后的影响
Fabiola A Bechtiger,Jörg Kaiser,Ingmar F Rompen et al.
Fabiola A Bechtiger et al.
Background: Sex-related differences in oncologic outcomes are well established in pancreatic adenocarcinoma, but evidence in pancreatic neuroendocrine neoplasms (pNEN) remains limited. This study analyses the association ...
Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma [0.03%]
新辅助化疗在病理性完全缓解的胰腺导管腺癌患者中的应用效果
Seif Elmankabadi,Amir G Ashraf,Laleh Foroutani et al.
Seif Elmankabadi et al.
Introduction: Achievement of pathologic complete response (pCR) following neoadjuvant chemotherapy (NAC) in patients with pancreatic ductal adenocarcinoma (PDAC) is associated with improved overall survival (OS). However,...
Prognostic value and spatial transcriptomic landscape of histopathological growth patterns in synchronous colorectal liver metastases [0.03%]
同步结直肠癌肝转移病灶生长模式的预后价值及其空间转录组学图谱
Zhu Lin,Xingyu Li,Taijun Yi et al.
Zhu Lin et al.
Background: Histopathological growth patterns (HGPs) are critical prognostic biomarkers in colorectal liver metastases (CRLM), yet their molecular drivers remain unclear. This study aims to validate the prognostic value o...
One-stage hepatectomy may be a safe and feasible alternative to ALPPS for hepatocellular carcinoma with liver fibrosis or cirrhosis and FLR/SLV ratio of 30% - 40% - A multicenter study [0.03%]
一期肝切除可能是一种安全可行的ALPPS替代方法用于治疗伴有肝纤维化或肝硬化且未来肝脏预留量占比为30%-40%的 hepatocellular carcinoma患者——一项多中心研究
Haojie Yang,Junping Gao,Shutian Mo et al.
Haojie Yang et al.
Objective and background: The optimal surgical strategy for patients with hepatocellular carcinoma (HCC) and liver fibrosis/cirrhosis presenting with a future liver remnant to standard liver volume (FLR/SLV) ratio of 30%-...